The Latest Cardiac and Vascular News
CARDIFF-BY-THE-SEA, Calif. and BOULDER, Colo., Dec. 13, 2022 /PRNewswire/ — Today, Field Medical, Inc. and CardioNXT, Inc. announce a strategic collaboration to provide the first-of-its-kind, purpose built, focal pulsed field ablation (PFA) therapy integrated seamlessly with 3D mapping & navigation. Both teams will harness decades of experience in pioneering novel PFA and navigation product […]
BOULDER, Colo., Aug. 18, 2021 /PRNewswire/ — CardioNXT announced today that it received marketing clearance from the U.S. Food and Drug Administration (FDA) for the platform technology comprised of the iMap 3D Navigation & Mapping System™, Activate Software™, Sensor Enabled Axis Patient Patches™, and MultiLink Sensor Enabled Catheter™. The CardioNXT technology platform enables […]
WESTMINSTER, Colo., June 6, 2018 /PRNewswire/ — CardioNXT and AFTx, related privately-held medical device companies, jointly announced today that the Real-time electrogram Analysis for Drivers of Atrial fibRillation (RADAR) clinical trial has reached full enrollment with 65 treated patients. The RADAR trial focuses on treating patients with Persistent and Long Standing Persistent Atrial Fibrillation (AF). The […]
